https://www.selleckchem.com/pr....oducts/n-ethylmaleim
00001), and the total effective rate of patients (OR=3.20, 95%CI 1.90 to 5.38, P0.0001). The differences in all indicators were statistically significant. WNM might have a significant effect on improving cognitive function and daily living ability, reducing the symptoms of AD, and increase the total effective rate. WNM is an effective non-pharmacological therapy for patients with AD. WNM might have a significant effect on improving cognitive function and daily living ability, reducing the symptoms of AD, and increase th
Like
Comment
Share
